Follow-The-Filings

Security · featured owners

AKBA Akebia Therapeutics Inc.

Health Care COM Equity among managers we track

AKBA (Akebia Therapeutics Inc.) 13F ownership among featured managers we track. Figures are as-filed 13F, not free float.

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

SEC filings

Recent issuer filings from EDGAR · 18 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01
10-Q
8-K 7.01,8.01,9.01
8-K 5.07
8-K 2.02,9.01
10-Q
DEFA14A
8-K 5.02,9.01
8-K 2.02,9.01
10-K
8-K 1.01,2.03,5.02,9.01
8-K 2.02,7.01,9.01
8-K 1.01,7.01,8.01,9.01
8-K 1.01
8-K 2.02,9.01
10-Q
8-K 7.01,8.01,9.01
10-Q

Insider forms

Form 3 / 4 / 5 from EDGAR · 7 rows shown

Filed Form Detail Links
4 Period Aug 6, 2026
4 Period Jun 29, 2026
4 Period Jun 17, 2026 · 6 forms
4 Period Apr 1, 2026
4 Period Mar 4, 2026
4 Period Feb 2, 2026 · 6 forms
4 Period Jan 30, 2026 · 6 forms

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $194.62M $160.18M $236.2M
Gross profit * $120.47M $97M $196.73M
Gross margin * 61.9% 60.6% 83.3%
Net income -$51.92M -$69.41M -$5.34M
Net margin * -26.7% -43.3% -2.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $118.15M $113.83M $252.96M
Total non-current assets * $123.55M $106.84M $123.61M
Total assets $241.7M $220.67M $376.56M
Total current liabilities $99.87M $80.91M $162.94M
Total non-current liabilities * $172.42M $188.94M $181.02M
Total equity -$30.58M -$49.18M $32.61M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$23.38M -$40.66M $67.99M
Cash from investing $0M -$0.033M -$7.93M
Cash from financing -$25.21M $49.66M $72.93M
Net change in cash -$48.59M $8.97M $132.99M

ownership over time

filing count by report period · click a bar for that quarter’s holders

period archive